Certain cancers disrupt metabolism, leading to the wasting syndrome known as cachexia. How tumor-induced mediators of cachexia induce changes in end organs is unclear. A study implicates the endothelium as an amplifier of tumor signals in fat, in which NOTCH1 promotes adipose tissue remodeling via retinoic acid, IL-33 and IGFBP3.
References
Roeland, E. J. et al. J. Clin. Oncol. 38, 2438–2453 (2020).
Kadakia, K. C., Hamilton-Reeves, J. M. & Baracos, V. E. Am. Soc. Clin. Oncol. Educ. Book 43, e389942 (2023).
Pryce, B. R., Wang, D. J., Zimmers, T. A., Ostrowski, M. C. & Guttridge, D. C. Cancer Cell 41, 581–584 (2023).
Yu, Y. C. et al. Front. Oncol. 12, 1057930 (2022).
Taylor, J. et al. Nat. Cancer https://doi.org/10.1038/s43018-023-00622-y (2023).
Rafii, S., Butler, J. M. & Ding, B. S. Nature 529, 316–325 (2016).
Preuss, S. F., Grieshober, D. & Augustin, H. G. Physiology (Bethesda) 38, 189–202 (2023).
Hasan, S. S. & Fischer, A. Trends Cell Biol. 31, 37–49 (2021).
Babic, A. et al. Nat. Commun. 14, 4317 (2023).
Rupert, J. E. et al. J. Exp. Med. 218 (2021).
Narasimhan, A. et al. Cancers (Basel) 13, 1975 (2021).
Das, S. K. et al. Science 333, 233–238 (2011).
Blaner, W. S. Pharmacol. Ther. 197, 153–178 (2019).
Zhdanovskaya, N. et al. Cancers (Basel) 13, 5106 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
T.A.Z. serves or has previously served on advisory boards and/or as a scientific advisory board member for PeleOS Technologies, LLC; Emmyon, Inc; Aveo; and Immuneering.
Rights and permissions
About this article
Cite this article
Counts, B.R., Zimmers, T.A. Endothelium directs fat remodeling in cachexia. Nat Cancer 4, 1531–1533 (2023). https://doi.org/10.1038/s43018-023-00644-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-023-00644-6
- Springer Nature America, Inc.